[Use of xylocaine in the treatment of ventricular arrhythmias appearing in the acute phase of myocardial infarct]. 1971

S Zanini, and F Cicogna, and M Mancuso, and P I Porciello, and G Salazzari, and E Strapparava

UI MeSH Term Description Entries
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D003325 Coronary Care Units The hospital unit in which patients with acute cardiac disorders receive intensive care. Care Unit, Coronary,Care Units, Coronary,Coronary Care Unit,Unit, Coronary Care,Units, Coronary Care
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Zanini, and F Cicogna, and M Mancuso, and P I Porciello, and G Salazzari, and E Strapparava
June 1973, Wiener klinische Wochenschrift,
S Zanini, and F Cicogna, and M Mancuso, and P I Porciello, and G Salazzari, and E Strapparava
January 1981, Revista espanola de cardiologia,
S Zanini, and F Cicogna, and M Mancuso, and P I Porciello, and G Salazzari, and E Strapparava
January 1970, Il Friuli medico,
S Zanini, and F Cicogna, and M Mancuso, and P I Porciello, and G Salazzari, and E Strapparava
January 1969, Malattie cardiovascolari,
S Zanini, and F Cicogna, and M Mancuso, and P I Porciello, and G Salazzari, and E Strapparava
December 1970, Lyon medical,
S Zanini, and F Cicogna, and M Mancuso, and P I Porciello, and G Salazzari, and E Strapparava
January 1980, Kardiologia polska,
S Zanini, and F Cicogna, and M Mancuso, and P I Porciello, and G Salazzari, and E Strapparava
April 1974, Giornale di clinica medica,
S Zanini, and F Cicogna, and M Mancuso, and P I Porciello, and G Salazzari, and E Strapparava
April 1970, Prensa medica argentina,
S Zanini, and F Cicogna, and M Mancuso, and P I Porciello, and G Salazzari, and E Strapparava
January 1980, Revista espanola de cardiologia,
S Zanini, and F Cicogna, and M Mancuso, and P I Porciello, and G Salazzari, and E Strapparava
January 1972, Giornale italiano di cardiologia,
Copied contents to your clipboard!